RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Experimental Neoplasms
Accession: DOID:9002170
browse the term
Definition: Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
Synonyms: exact_synonym: Experimental Neoplasm
primary_id: MESH:D009374
alt_id: RDO:0005115
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19878872
NCBI chr 3:10,041,820...10,145,076
Ensembl chr 3:10,041,826...10,144,388 Ensembl chr 3:10,041,826...10,144,388
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9496914
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
G
Arl6ip5
ADP-ribosylation factor like GTPase 6 interacting protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29545876
NCBI chr 4:129,574,363...129,598,240
Ensembl chr 4:129,574,264...129,598,915
G
Arnt
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9496914
NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
G
Axl
Axl receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26206560
NCBI chr 1:82,550,892...82,580,761
Ensembl chr 1:82,549,420...82,580,761
G
Bcr
BCR activator of RhoGEF and GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19878872
NCBI chr20:14,421,250...14,546,406
Ensembl chr20:14,421,141...14,545,772
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 4:67,389,331...67,520,549
Ensembl chr 4:67,396,192...67,520,356
G
Bsg
basigin (Ok blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21165561
NCBI chr 7:12,875,536...12,882,753
Ensembl chr 7:12,875,537...12,882,753
G
Ccnd1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27224422
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdk4
cyclin-dependent kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
G
Eno2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22613180
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047 Ensembl chr 9:157,285,179...157,294,047
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14612517
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
G
Ergic3
ERGIC and golgi 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27588471
NCBI chr 3:151,553,567...151,563,318
Ensembl chr 3:151,553,578...151,563,364
G
F2r
coagulation factor II (thrombin) receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374729
NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21273587
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28574600
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3433577 PMID:11552296 PMID:26558449
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
G
Hrh2
histamine receptor H 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6224980
NCBI chr17:10,912,959...10,931,389
Ensembl chr17:10,921,507...10,952,441
G
Ifnb1
interferon beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2297754
NCBI chr 5:106,865,192...106,865,746
Ensembl chr 5:106,865,192...106,865,746
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15711825
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Il12a
interleukin 12A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17332360
NCBI chr 2:165,076,945...165,083,996
Ensembl chr 2:165,076,607...165,084,318
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17332360
NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085
G
Il2
interleukin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1949363 PMID:3495671 PMID:22306178
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
G
Kif11
kinesin family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17974955
NCBI chr 1:256,035,866...256,088,299
Ensembl chr 1:256,035,866...256,088,299
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9205081 PMID:10813127 PMID:21311774 PMID:25851810 PMID:26390243
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Ldha
lactate dehydrogenase A
IMP
RGD
PMID:11085542
RGD:1600281
NCBI chr 1:102,900,288...102,909,713
Ensembl chr 1:102,900,286...102,909,707
G
Lect2
leukocyte cell-derived chemotaxin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30453282
NCBI chr17:8,489,261...8,495,483
Ensembl chr17:8,489,266...8,495,496
G
Mapk7
mitogen-activated protein kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29507229
NCBI chr10:47,768,592...47,775,130
Ensembl chr10:47,766,680...47,775,055 Ensembl chr10:47,766,680...47,775,055
G
Mir143
microRNA 143
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28736328 PMID:31152816
NCBI chr18:56,971,273...56,971,377
Ensembl chr18:56,971,273...56,971,377
G
Mir300
microRNA 300
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,874,152...133,874,230
Ensembl chr 6:133,874,144...133,874,233
G
Mir323
microRNA 323
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,861,199...133,861,284
Ensembl chr 6:133,861,199...133,861,284
G
Mir337
microRNA 337
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,705,920...133,706,016
Ensembl chr 6:133,705,920...133,706,016
G
Mir34b
microRNA 34b
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22113133
NCBI chr 8:55,492,542...55,492,625
Ensembl chr 8:55,492,542...55,492,625
G
Mir370
microRNA 370
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,739,916...133,739,994
Ensembl chr 6:133,739,916...133,739,994
G
Mir381
microRNA 381
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,876,615...133,876,675
Ensembl chr 6:133,876,586...133,876,693
G
Mir431
microRNA 431
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,711,425...133,711,538
Ensembl chr 6:133,711,425...133,711,538
G
Mir433
microRNA 433
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,712,334...133,712,426
Ensembl chr 6:133,712,334...133,712,426
G
Mir487b
microRNA 487b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,877,124...133,877,205
Ensembl chr 6:133,877,124...133,877,205
G
Mir770
microRNA 770
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,682,965...133,683,040
Ensembl chr 6:133,682,957...133,683,050
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:9496914 PMID:21034357
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9205081
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Parg
poly (ADP-ribose) glycohydrolase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33044785
NCBI chr16:8,350,168...8,457,999
Ensembl chr16:8,350,326...8,457,996
G
Pcna
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
G
Polr1h
RNA polymerase I subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16609701
NCBI chr20:2,088,518...2,092,436
Ensembl chr20:2,088,533...2,092,436
G
Prnp
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21265952
NCBI chr 3:124,515,917...124,531,320
Ensembl chr 3:124,515,978...124,531,316
G
Puf60
poly-U binding splicing factor 60
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21435101
NCBI chr 7:117,129,237...117,140,234
Ensembl chr 7:117,129,237...117,140,214
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27137931
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Sparc
secreted protein acidic and cysteine rich
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20164124
NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21852811
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29507229
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Stim1
stromal interaction molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27863410
NCBI chr 1:167,373,894...167,533,412
Ensembl chr 1:167,373,678...167,533,420
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1674182 PMID:3361654 PMID:12627504
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 Ensembl chr20:5,189,390...5,192,000
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17767197 PMID:24345465
NCBI chr 2:113,008,008...113,026,899
Ensembl chr 2:113,007,549...113,026,899
G
Tob1
transducer of ErbB-2.1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12756225
NCBI chr10:81,913,689...81,915,727
Ensembl chr10:81,913,689...81,915,716
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12756225 PMID:27137931
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tp63
tumor protein p63
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25739959
NCBI chr11:78,234,853...78,456,559
Ensembl chr11:78,234,800...78,456,501
G
Trim47
tripartite motif-containing 47
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31981573
NCBI chr10:104,654,717...104,659,188
Ensembl chr10:104,654,717...104,659,188
G
Txn1
thioredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28574600
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
G
Uri1
URI1, prefoldin-like chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21397856
NCBI chr 1:94,346,513...94,404,362
Ensembl chr 1:94,346,514...94,404,211
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:20376344 PMID:20932960 PMID:28574600
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
C3
complement C3
treatment
ISO
RGD
PMID:16947020
RGD:7401280
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
G
Coq7
coenzyme Q7, hydroxylase
susceptibility
ISO
RGD
PMID:23166727
RGD:10402105
NCBI chr 1:188,176,060...188,190,874
Ensembl chr 1:188,174,874...188,190,860
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:16767432
RGD:8655941
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
G
Il2
interleukin 2
treatment
ISO
RGD
PMID:9399664
RGD:8663451
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
G
Irak3
interleukin-1 receptor-associated kinase 3
ISO
RGD
PMID:21278795
RGD:36049796
NCBI chr 7:64,922,830...64,982,224
Ensembl chr 7:64,923,615...64,982,281
G
Jam3
junctional adhesion molecule 3
ISO
RGD
PMID:15994945
RGD:7488936
NCBI chr 8:28,147,110...28,208,466
Ensembl chr 8:28,147,111...28,208,466
G
Lect2
leukocyte cell-derived chemotaxin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30453282
NCBI chr17:8,489,261...8,495,483
Ensembl chr17:8,489,266...8,495,496
G
Txnrd1
thioredoxin reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16565519
NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400
G
Cd40
CD40 molecule
treatment
IDA
RGD
PMID:19269163
RGD:11352683
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
G
Cd40lg
CD40 ligand
treatment
IDA
RGD
PMID:19269163
RGD:11352683
NCBI chr X:159,703,703...159,714,886
Ensembl chr X:159,703,578...159,716,562
G
Cbl
Cbl proto-oncogene
treatment
ISO
RGD
PMID:20890046
RGD:11038805
NCBI chr 8:48,481,256...48,564,775
Ensembl chr 8:48,489,036...48,564,722
G
Cbx7
chromobox 7
ISO
RGD
PMID:25434821
RGD:11352713
NCBI chr 7:121,136,067...121,153,503
Ensembl chr 7:121,136,058...121,153,383
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO
RGD
PMID:10090949
RGD:11251764
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
G
Fgfr1
Fibroblast growth factor receptor 1
treatment
ISO
RGD
PMID:22781593
RGD:11352669
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
G
Il1a
interleukin 1 alpha
treatment
ISO
RGD
PMID:2117483
RGD:11051972
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
G
Nras
NRAS proto-oncogene, GTPase
induced
IAGP
DNA:transversion mutation, loss of heterozygosity:cds:
RGD
PMID:9142215
RGD:11535063
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Runx1
RUNX family transcription factor 1
treatment
ISO
RGD
PMID:19236814
RGD:11251683
NCBI chr11:32,765,147...33,003,061
Ensembl chr11:32,769,165...33,003,021
G
Abcb11
ATP binding cassette subfamily B member 11
IDA
RGD
PMID:15853769
RGD:1598580
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
IEP
RGD
PMID:8104413
RGD:5684351
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
G
Adsl
adenylosuccinate lyase
IEP
protein:increased activity:liver (rat)
RGD
PMID:2937404
RGD:1598766
NCBI chr 7:122,157,201...122,192,328
Ensembl chr 7:122,157,201...122,192,328
G
Afp
alpha-fetoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24012840
NCBI chr14:19,141,755...19,159,919
Ensembl chr14:19,141,755...19,159,923
G
Agps
alkylglycerone phosphate synthase
IDA
RGD
PMID:7407223
RGD:1598794
NCBI chr 3:62,648,352...62,749,250
Ensembl chr 3:62,648,447...62,749,153
G
Alas2
5'-aminolevulinate synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:23,167,576...23,187,356
Ensembl chr X:23,167,696...23,187,341
G
Apoa4
apolipoprotein A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
G
Apoc2
apolipoprotein C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:80,589,023...80,593,991
Ensembl chr 1:80,589,023...80,594,136
G
Arrb2
arrestin, beta 2
IEP
mRNA, protein:increased expression:liver (rat)
RGD
PMID:21167192
RGD:5509890
NCBI chr10:57,040,252...57,048,045
Ensembl chr10:57,040,267...57,048,134
G
Atp7a
ATPase copper transporting alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr X:77,076,085...77,193,644
Ensembl chr X:77,076,106...77,193,644
G
Atp7b
ATPase copper transporting beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr16:74,865,516...74,944,935
Ensembl chr16:74,865,516...74,945,286
G
Bak1
BCL2-antagonist/killer 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
G
Bbc3
Bcl-2 binding component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:78,261,491...78,267,802
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10426811 PMID:28100771
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l1
Bcl2-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10426811 PMID:28100771 , PMID:22414765
RGD:11353865
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Birc5
baculoviral IAP repeat-containing 5
IEP
mRNA, protein:increased expression:liver
RGD
PMID:18246794
RGD:2293125
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Ca3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
IEP
protein:increased activity:liver (rat)
RGD
PMID:13618893
RGD:5132586
NCBI chr 6:26,657,507...26,680,459
Ensembl chr 6:26,657,780...26,680,284
G
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30603057
NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
G
Ccnb1
cyclin B1
IEP
mRNA:increased expression:liver
RGD
PMID:17342310
RGD:2315991
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
G
Ccnd1
cyclin D1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771 , PMID:17055752
RGD:2289139
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Ccndbp1
cyclin D1 binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16501603
NCBI chr 3:112,951,065...112,961,620
Ensembl chr 3:112,950,890...112,961,614
G
Cd40lg
CD40 ligand
ISO
RGD
PMID:19035311
RGD:5491179
NCBI chr X:159,703,703...159,714,886
Ensembl chr X:159,703,578...159,716,562
G
Cd63
Cd63 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 7:3,320,250...3,335,583
Ensembl chr 7:3,320,103...3,335,582
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:25319454
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
IEP
protein:decreased expression:liver:
RGD
PMID:8640740
RGD:8662309
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
G
Cps1
carbamoyl-phosphate synthase 1
severity
IEP
mRNA:decreased expression:liver
RGD
PMID:3387993
RGD:2303406
NCBI chr 9:74,113,437...74,236,274
Ensembl chr 9:74,124,016...74,236,274
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11280770 PMID:20118494 PMID:21147764
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr14:17,228,832...17,233,743
Ensembl chr14:17,228,856...17,234,712
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
mRNA:increased expression:liver
RGD
PMID:22687991
RGD:7296954
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11376689 PMID:21147764
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:147,236,480...147,307,988
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18056438
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
G
Cyp2f4
cytochrome P450, family 2, subfamily f, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:83,933,974...83,947,804
Ensembl chr 1:83,933,942...83,947,821
G
Dhodh
dihydroorotate dehydrogenase (quinone)
IEP
protein:increased activity:liver (rat)
RGD
PMID:6331524
RGD:5132618
NCBI chr19:42,066,103...42,087,906
Ensembl chr19:42,066,351...42,082,012
G
Dtymk
deoxythymidylate kinase
IEP
protein:increased activity:tumor (rat)
RGD
PMID:6244089
RGD:5133686
NCBI chr 9:100,921,565...100,930,399
Ensembl chr 9:100,921,565...100,930,399
G
Eno2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047 Ensembl chr 9:157,285,179...157,294,047
G
Ephx1
epoxide hydrolase 1
IEP
RGD
PMID:7260898
RGD:11252158
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
G
F12
coagulation factor XII
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr17:9,736,577...9,744,420
Ensembl chr17:9,736,577...9,744,420
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Foxm1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15082532
NCBI chr 4:161,685,236...161,697,633
Ensembl chr 4:161,685,258...161,696,305
G
Gjb1
gap junction protein, beta 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18308698 , PMID:1336494
RGD:7349398
NCBI chr X:71,272,030...71,279,973
Ensembl chr X:71,272,042...71,279,977
G
Gjb2
gap junction protein, beta 2
IEP
RGD
PMID:1336494
RGD:7349398
NCBI chr15:37,377,313...37,394,494
Ensembl chr15:37,377,316...37,383,277
G
Glul
glutamate-ammonia ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:21147764
NCBI chr13:71,331,052...71,340,207
Ensembl chr13:71,331,052...71,340,229
G
Grp
gastrin releasing peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr18:61,563,458...61,576,818
Ensembl chr18:61,563,053...61,576,818
G
Gstp1
glutathione S-transferase pi 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2563599 PMID:3124819 PMID:7585603 PMID:20188851 , PMID:12016164
RGD:2317823
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
G
H19
H19, imprinted maternally expressed transcript (non-protein coding)
IDA
DNA:hypomethylation:promoter
RGD
PMID:15352122
RGD:1342455
NCBI chr 1:215,744,404...215,747,080
G
Hat1
histone acetyltransferase 1
IEP
protein:increased expression:liver
RGD
PMID:17182829
RGD:2316578
NCBI chr 3:58,022,395...58,070,067
Ensembl chr 3:58,022,238...58,070,068
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11896611
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
G
Htr2c
5-hydroxytryptamine receptor 2C
IEP
protein:increased expression:brainstem, cerebral cortex
RGD
PMID:17258772
RGD:1624998
NCBI chr X:118,084,520...118,318,040
Ensembl chr X:118,084,890...118,318,039
G
Igf2
insulin-like growth factor 2
treatment
IEP
RGD
PMID:22425635
RGD:10402567
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
G
Igf2r
insulin-like growth factor 2 receptor
IAGP
RGD
PMID:15057872 , PMID:9652747
RGD:2311623 , RGD:2311630
NCBI chr 1:48,176,095...48,264,482
Ensembl chr 1:48,176,106...48,264,477
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr X:156,254,187...156,280,046
Ensembl chr X:156,257,173...156,270,748
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26297436
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Insr
insulin receptor
disease_progression
IEP
associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat)
RGD
PMID:15520221
RGD:2306052
NCBI chr12:1,682,527...1,816,414
Ensembl chr12:1,680,957...1,816,414
G
Jak2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
G
Kat6a
lysine acetyltransferase 6A
IEP
protein:increased expression:liver (rat)
RGD
PMID:17083329
RGD:2312274
NCBI chr16:73,942,669...74,020,750
Ensembl chr16:73,943,455...74,023,005
G
Kdr
kinase insert domain receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603461
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Map2k1
mitogen activated protein kinase kinase 1
IEP
associated with Diabetes Mellitus, Experimental;protein:increased expression:liver
RGD
PMID:15520221
RGD:2306052
NCBI chr 8:69,134,218...69,722,573
Ensembl chr 8:69,134,223...69,164,758
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:140,845,478...140,860,882
Ensembl chr 1:140,845,465...140,860,894
G
Mir10a
microRNA 10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:84,165,950...84,166,059
Ensembl chr10:84,165,950...84,166,059
G
Mir125a
microRNA 125a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:59,704,827...59,704,911
Ensembl chr 1:59,704,827...59,704,911
G
Mir145
microRNA 145
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr18:56,969,907...56,969,994
Ensembl chr18:56,969,907...56,969,994
G
Mir151
microRNA 151
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:114,485,547...114,485,643
G
Mir181c
microRNA 181c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr19:25,290,211...25,290,316
Ensembl chr19:25,290,211...25,290,316
G
Mir181d
microRNA 181d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr19:25,290,051...25,290,133
Ensembl chr19:25,290,051...25,290,133
G
Mir183
microRNA 183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:57,463,569...57,463,678
Ensembl chr 4:57,463,569...57,463,678
G
Mir186
microRNA 186
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:263,873,759...263,873,844
Ensembl chr 2:263,873,759...263,873,844
G
Mir18a
microRNA 18a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr15:100,180,015...100,180,110
Ensembl chr15:100,180,015...100,180,110
G
Mir195
microRNA 195
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:56,845,301...56,845,387
Ensembl chr10:56,845,301...56,845,387
G
Mir196b
microRNA 196b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:82,199,056...82,199,140
Ensembl chr 4:82,199,056...82,199,140
G
Mir200b
microRNA 200b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:173,490,144...173,490,238
Ensembl chr 5:173,490,144...173,490,238
G
Mir206
microRNA 206
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:26,791,764...26,791,847
Ensembl chr 9:26,791,764...26,791,847
G
Mir212
microRNA 212
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:62,014,702...62,014,812
Ensembl chr10:62,014,702...62,014,812
G
Mir221
microRNA 221
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:3,684,480...3,684,588
Ensembl chr X:3,684,480...3,684,588
G
Mir26a
microRNA 26a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 8:127,714,441...127,714,530
Ensembl chr 8:127,714,441...127,714,530
G
Mir26b
microRNA 26b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:81,675,275...81,675,359
Ensembl chr 9:81,675,275...81,675,359
G
Mir290
microRNA 290
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:64,538,705...64,538,785
Ensembl chr 1:64,538,705...64,538,785
G
Mir300
microRNA 300
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:133,874,152...133,874,230
Ensembl chr 6:133,874,144...133,874,233
G
Mir301a
microRNA 301a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:74,417,746...74,417,845
Ensembl chr10:74,417,746...74,417,845
G
Mir30a
microRNA 30a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:29,542,635...29,542,705
Ensembl chr 9:29,542,635...29,542,705
G
Mir30b
microRNA 30b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:109,282,662...109,282,747
Ensembl chr 7:109,282,658...109,282,752
G
Mir30d
microRNA 30d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:109,286,463...109,286,544
Ensembl chr 7:109,286,463...109,286,544
G
Mir30e
microRNA 30e
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:139,702,872...139,702,963
Ensembl chr 5:139,702,872...139,702,963
G
Mir324
microRNA 324
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:56,621,126...56,621,208
Ensembl chr10:56,621,124...56,621,212
G
Mir331
microRNA 331
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:34,881,095...34,881,190
Ensembl chr 7:34,881,095...34,881,190
G
Mir336
microRNA 336
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr10:35,349,756...35,349,851
Ensembl chr10:35,349,756...35,349,851
G
Mir339
microRNA 339
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr12:17,369,002...17,369,097
Ensembl chr12:17,369,002...17,369,097
G
Mir347
microRNA mir-347
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
G
Mir349
microRNA 349
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:130,146,518...130,146,614
Ensembl chr 7:130,146,518...130,146,614
G
Mir34a
microRNA 34a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:167,092,491...167,092,592
Ensembl chr 5:167,092,491...167,092,592
G
Mir352
microRNA mir-352
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
G
Mir383
microRNA 383
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr16:57,519,675...57,519,748
Ensembl chr16:57,519,675...57,519,748
G
Mir409
microRNA 409
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:133,893,419...133,893,495
G
Mir429
microRNA 429
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:173,488,331...173,488,415
Ensembl chr 5:173,488,331...173,488,415
G
Mir598
microRNA 598
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr15:47,057,496...47,057,574
Ensembl chr15:47,057,496...47,057,575
G
Mir652
microRNA 652
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:114,002,534...114,002,614
Ensembl chr X:114,002,534...114,002,614
G
Mir671
microRNA 671
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:7,108,747...7,108,827
Ensembl chr 4:7,108,738...7,108,835
G
Mir708
microRNA 708
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:161,221,246...161,221,333
Ensembl chr 1:161,221,246...161,221,333
G
Mir760
microRNA 760
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:225,873,354...225,873,433
Ensembl chr 2:225,873,354...225,873,433
G
Mir92b
microRNA 92b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:188,541,034...188,541,116
Ensembl chr 2:188,541,034...188,541,116
G
Mir98
microRNA 98
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:21,583,875...21,583,982
Ensembl chr X:21,583,875...21,583,982
G
Mir99b
microRNA 99b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:59,704,216...59,704,285
Ensembl chr 1:59,704,216...59,704,285
G
Mirlet7b
microRNA let-7b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:126,590,627...126,590,711
Ensembl chr 7:126,590,627...126,590,711
G
Mirlet7d
microRNA let-7d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr17:16,419,980...16,420,077
Ensembl chr17:16,419,980...16,420,077
G
Mirlet7i
microRNA let-7i
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:66,802,731...66,802,815
Ensembl chr 7:66,802,732...66,802,821
G
Mmp2
matrix metallopeptidase 2
IEP ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression, increased activity:liver
CTD
PMID:30603057 , PMID:19528495 , PMID:19539802
RGD:2325736 , RGD:2325734
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp9
matrix metallopeptidase 9
IEP
mRNA, protein:increased expression, increased activity:liver
RGD
PMID:19528495 , PMID:19539802
RGD:2325736 , RGD:2325734
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Mpeg1
macrophage expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 1:228,724,559...228,729,054
Ensembl chr 1:228,724,900...228,727,160
G
Myc
MYC proto-oncogene, bHLH transcription factor
IEP ISO
mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism
CTD
PMID:9079223 PMID:11280770 PMID:18560566 , PMID:3335218
RGD:10059623
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
G
Nos2
nitric oxide synthase 2
IEP
protein:increased expression:liver
RGD
PMID:10383909
RGD:2325277
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Notch1
notch receptor 1
IEP
protein:increased expression:liver
RGD
PMID:18942116
RGD:2325310
NCBI chr 3:3,905,562...3,951,015
Ensembl chr 3:3,905,453...3,951,025
G
Nqo1
NAD(P)H quinone dehydrogenase 1
IEP
mRNA, protein:increased expression:liver (rat)
RGD
PMID:27867096
RGD:13442478
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
susceptibility
ISO
RGD
PMID:17283114
RGD:14701032
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17172636 PMID:24769335 PMID:25656644
NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
G
Nras
NRAS proto-oncogene, GTPase
ISO
human gene in mouse model
RGD
PMID:16286660
RGD:14975105
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Pemt
phosphatidylethanolamine N-methyltransferase
IEP
protein:decreased expression:liver
RGD
PMID:7929120
RGD:1642378
NCBI chr10:46,339,821...46,404,640
Ensembl chr10:46,339,821...46,404,642
G
Pml
PML nuclear body scaffold
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20377131
NCBI chr 8:63,002,515...63,034,310
Ensembl chr 8:63,004,870...63,034,226
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:761203
NCBI chr14:33,580,541...33,614,919
Ensembl chr14:33,580,541...33,614,919
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:2562181
RGD:8693574
NCBI chr10:37,534,449...37,554,861
Ensembl chr10:37,535,871...37,554,664
G
Prdx1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27517622
NCBI chr 5:135,536,413...135,551,986
Ensembl chr 5:135,536,413...135,551,990
G
Ptgr1
prostaglandin reductase 1
IEP
protein:increased expression:liver
RGD
PMID:24853774
RGD:14401713
NCBI chr 5:76,110,746...76,129,361
Ensembl chr 5:76,110,738...76,129,441
G
Rad51
RAD51 recombinase
IEP
protein:decreased expression:liver
RGD
PMID:17219426
RGD:2292638
NCBI chr 3:110,918,240...110,942,920
Ensembl chr 3:110,918,243...110,942,917
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17854601
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
G
Rgn
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:1,833,484...1,848,904
Ensembl chr X:1,833,492...1,848,904
G
Rida
reactive intermediate imine deaminase A homolog
IEP
protein:increased expression:liver (rat)
RGD
PMID:12939504
RGD:9685719
NCBI chr 7:73,256,506...73,270,308
Ensembl chr 7:73,256,508...73,270,308
G
Rras2
RAS related 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr 1:178,940,515...179,010,257
Ensembl chr 1:178,940,516...179,010,257
G
Rrm1
ribonucleotide reductase catalytic subunit M1
IEP
RGD
PMID:15224347
RGD:2316863
NCBI chr 1:167,538,387...167,562,688
Ensembl chr 1:167,538,263...167,562,688
G
Rxra
retinoid X receptor alpha
IEP
mRNA, protein:decreased expression:liver
RGD
PMID:17786350
RGD:1643105
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
G
Serpina1
serpin family A member 1
IEP
RGD
PMID:10569800
RGD:1626391
NCBI chr 6:127,610,241...127,632,265
Ensembl chr 6:127,610,243...127,632,265
G
Slc31a1
solute carrier family 31 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr 5:78,222,504...78,249,358
Ensembl chr 5:78,222,504...78,249,358
G
Socs1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15197228
NCBI chr10:4,956,795...4,958,472
Ensembl chr10:4,957,326...4,958,461
G
Sox4
SRY-box transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr17:37,615,022...37,619,728
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
G
Sqle
squalene epoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 7:99,609,929...99,624,803
Ensembl chr 7:99,609,191...99,624,732
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26297436 PMID:28100771
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Tek
TEK receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr 5:113,725,717...113,852,799
Ensembl chr 5:113,725,717...113,852,799
G
Tgfa
transforming growth factor alpha
IEP ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD
PMID:9079223 , PMID:16734725
RGD:2317490
NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
G
Tk1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr10:106,817,556...106,828,888
Ensembl chr10:106,817,601...106,828,884
G
Tnf
tumor necrosis factor
treatment
ISO
CTD Direct Evidence: marker/mechanism Morris hepatoma
CTD
PMID:28100771 , PMID:9063767
RGD:14696818
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 Ensembl chr20:5,189,390...5,192,000
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10626228 PMID:28100771
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15833021 PMID:17533171
NCBI chr15:58,554,358...58,658,156
Ensembl chr15:58,554,374...58,658,153
G
Vim
vimentin
IDA
RGD
PMID:19199359
RGD:6480440
NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
G
Xdh
xanthine dehydrogenase
IEP
protein:decreased expression:liver
RGD
PMID:3460692
RGD:13210515
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
G
Acss1
acyl-CoA synthetase short-chain family member 1
treatment
ISO
RGD
PMID:27539851
RGD:13831304
NCBI chr 3:146,420,346...146,470,293
Ensembl chr 3:146,420,346...146,470,293
G
Acss2
acyl-CoA synthetase short-chain family member 2
treatment
ISO
RGD
PMID:27539851
RGD:13831304
NCBI chr 3:151,032,925...151,075,856
Ensembl chr 3:151,032,952...151,075,856
G
Antxr1
ANTXR cell adhesion molecule 1
treatment
ISO
RGD
PMID:19622764 , PMID:19609240
RGD:9684925 , RGD:9684939
NCBI chr 4:118,946,267...119,131,202
Ensembl chr 4:118,946,268...119,131,202
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29179997 PMID:29438700
NCBI chr 4:67,389,331...67,520,549
Ensembl chr 4:67,396,192...67,520,356
G
Calr
calreticulin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16388313
NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
G
Ccl20
C-C motif chemokine ligand 20
treatment
ISO
RGD
PMID:14500387
RGD:7483600
NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
treatment
ISO
RGD
PMID:24041689
RGD:7411680
NCBI chr 9:67,699,397...67,706,068
Ensembl chr 9:67,699,379...67,706,065
G
Egr1
early growth response 1
ISO
mRNA, protein:increased expression:salivary gland (mouse)
RGD
PMID:19517020
RGD:5131885
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
G
Esr2
estrogen receptor 2
severity
ISO
RGD
PMID:20354658
RGD:8694122
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
G
Hgf
hepatocyte growth factor
ISO
RGD
PMID:9823327
RGD:8548620
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
G
Ifnb1
interferon beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16417267
NCBI chr 5:106,865,192...106,865,746
Ensembl chr 5:106,865,192...106,865,746
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
ISO
RGD
PMID:19276165
RGD:7495758
NCBI chr16:74,177,233...74,230,809
Ensembl chr16:74,177,215...74,230,815
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:12230493 , PMID:17411412
RGD:8655870 , RGD:8655901
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
G
Il1a
interleukin 1 alpha
treatment
ISO
RGD
PMID:8061895
RGD:7794735
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
G
Il1b
interleukin 1 beta
ISO
RGD
PMID:1966551
RGD:7401226
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il2
interleukin 2
ISO
RGD
PMID:11884028
RGD:8662950
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
G
Kdm1a
lysine demethylase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29438700
NCBI chr 5:154,909,003...154,965,171
Ensembl chr 5:154,909,003...154,965,171
G
Kdm4c
lysine demethylase 4C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29438700
NCBI chr 5:90,800,139...91,012,662
Ensembl chr 5:90,800,082...91,012,659
G
Mc1r
melanocortin 1 receptor
ISO
RGD
PMID:20126537
RGD:5687319
NCBI chr19:56,215,420...56,219,987
G
Pdcd1
programmed cell death 1
treatment
ISO
RGD
PMID:19208793
RGD:9589070
NCBI chr 9:101,305,742...101,319,937
Ensembl chr 9:101,307,764...101,319,845 Ensembl chr 9:101,307,764...101,319,845
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29179997
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
G
Pxn
paxillin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18492274
NCBI chr12:46,797,953...46,845,107
Ensembl chr12:46,797,954...46,845,080
G
Tert
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:19903903
RGD:11038656
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
G
Agps
alkylglycerone phosphate synthase
IDA
RGD
PMID:7407223
RGD:1598794
NCBI chr 3:62,648,352...62,749,250
Ensembl chr 3:62,648,447...62,749,153
G
Alb
albumin
ISO
mRNA,protein:decreased expression:liver,serum:
RGD
PMID:1900492
RGD:11035284
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
G
Epo
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9743294
NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
G
Ifng
interferon gamma
treatment
ISO
RGD
PMID:2119881
RGD:10755752
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Kras
KRAS proto-oncogene, GTPase
IAGP
A to T transversion; Gln to His substitution
RGD
PMID:11295286
RGD:1598680
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Nras
NRAS proto-oncogene, GTPase
IAGP
DNA:transversion:exon p.Q61L (human)
RGD
PMID:11295286
RGD:1598680
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Slc6a14
solute carrier family 6 member 14
IEP
mRNA, protein:increased expression:brush border epithelial cell
RGD
PMID:17006743
RGD:1625275
NCBI chr X:120,624,522...120,647,964
Ensembl chr X:120,624,518...120,649,111
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
RGD
PMID:19654309
RGD:2315553
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14633655 , PMID:19654309
RGD:2315553
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
G
Abcg2
ATP binding cassette subfamily G member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22767648
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
G
Actb
actin, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
G
Actg1
actin, gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:109,518,429...109,521,288
Ensembl chr 3:75,643,054...75,644,954 Ensembl chr10:75,643,054...75,644,954
G
Actn4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
G
Adcy5
adenylate cyclase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr11:68,695,839...68,842,452
Ensembl chr11:68,695,839...68,842,320
G
Adipoq
adiponectin, C1Q and collagen domain containing
disease_progression treatment
ISO IEP
RGD
PMID:19447866 , PMID:22246620
RGD:8694414 , RGD:8694468
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
G
Afp
alpha-fetoprotein
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16322315
NCBI chr14:19,141,755...19,159,919
Ensembl chr14:19,141,755...19,159,923
G
Agt
angiotensinogen
treatment
IDA
RGD
PMID:20837666
RGD:5129167
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
G
Agtr1a
angiotensin II receptor, type 1a
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8389152 , PMID:18421211
RGD:2292665
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
G
Agtr2
angiotensin II receptor, type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8389152
NCBI chr X:119,389,480...119,393,845
Ensembl chr X:119,390,013...119,393,842
G
Akt1
AKT serine/threonine kinase 1
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Akt2
AKT serine/threonine kinase 2
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chr 1:84,400,939...84,451,223
Ensembl chr 1:84,411,726...84,450,162
G
Alcam
activated leukocyte cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr11:50,780,735...50,985,083
Ensembl chr11:50,781,127...50,985,083
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
IEP
mRNA:increased expression:mammary gland tumor (rat)
RGD
PMID:18959458
RGD:2313895
NCBI chr12:6,854,930...6,879,112
Ensembl chr12:6,854,920...6,879,154
G
Antxr1
ANTXR cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:22085271
RGD:9684855
NCBI chr 4:118,946,267...119,131,202
Ensembl chr 4:118,946,268...119,131,202
G
Anxa1
annexin A1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942 , PMID:16316942
RGD:2306898
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
G
Anxa4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
G
Apaf1
apoptotic peptidase activating factor 1
IDA
RGD
PMID:14973070
RGD:2325748
NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
G
Apoe
apolipoprotein E
ISO
RGD
PMID:22469977
RGD:7771597
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
G
Aqp1
aquaporin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
G
Ar
androgen receptor
IEP
RGD
PMID:12150826
RGD:6482679
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
G
Areg
amphiregulin
ISO IEP
protein:increased expression:mammary gland mRNA:increased expression:mammary gland
RGD
PMID:10225449 , PMID:18421211
RGD:2292663 , RGD:2292665
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
G
Atp5if1
ATP synthase inhibitory factor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 5:150,719,570...150,723,287
Ensembl chr 5:150,719,569...150,723,321
G
Aurka
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12124350
NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
G
Bad
BCL2-associated agonist of cell death
treatment severity
IDA IEP
RGD
PMID:23404339 , PMID:20732338
RGD:10053670 , RGD:10053708
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
G
Bak1
BCL2-antagonist/killer 1
ISO
RGD
PMID:19222350
RGD:2315700
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
G
Bard1
BRCA1 associated RING domain 1
ISO
RGD
PMID:18443292
RGD:2293149
NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
G
Basp1
brain abundant, membrane attached signal protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:77,586,424...77,632,626
Ensembl chr 2:77,586,424...77,632,628
G
Bax
BCL2 associated X, apoptosis regulator
treatment severity
IDA IEP
RGD
PMID:23404339 , PMID:20732338
RGD:10053670 , RGD:10053708
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcl2
BCL2, apoptosis regulator
treatment
IDA
RGD
PMID:23404339 , PMID:22668016
RGD:10053670 , RGD:10054128
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l1
Bcl2-like 1
treatment
IDA
RGD
PMID:23404339
RGD:10053670
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Brca1
BRCA1, DNA repair associated
susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12203372 PMID:22767648 , PMID:18443292 , PMID:12203372 , PMID:17505536
RGD:2293149 , RGD:1599502 , RGD:2293155
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
G
Bst2
bone marrow stromal cell antigen 2
disease_progression
ISO
RGD
PMID:23806386 , PMID:23806386
RGD:14398495 , RGD:14398495
NCBI chr16:19,938,781...19,942,353
Ensembl chr16:19,938,784...19,942,353
G
Ca9
carbonic anhydrase 9
IEP
RGD
PMID:17280655
RGD:2293194
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
disease_progression
IEP
protein:increased expression:mammary gland
RGD
PMID:6030068
RGD:2303540
NCBI chr 6:26,657,507...26,680,459
Ensembl chr 6:26,657,780...26,680,284
G
Capzb
capping actin protein of muscle Z-line subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:157,642,742...157,742,487
Ensembl chr 5:157,642,751...157,742,478
G
Cask
calcium/calmodulin dependent serine protein kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr X:9,815,652...10,156,155
Ensembl chr X:9,815,652...10,156,155 Ensembl chr X:9,815,652...10,156,155
G
Casp1
caspase 1
IEP
RGD
PMID:10557324
RGD:2315886
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
G
Casp3
caspase 3
treatment severity
IDA IEP
RGD
PMID:23404339 , PMID:26699876 , PMID:20732338
RGD:10053670 , RGD:13782283 , RGD:10053708
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp7
caspase 7
treatment
IDA ISO
RGD
PMID:23404339 , PMID:26699876 , PMID:23979166
RGD:10053670 , RGD:13782283 , RGD:13209143
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
G
Casp8
caspase 8
severity
IEP
RGD
PMID:20732338
RGD:10053708
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Casp9
caspase 9
treatment severity
IDA IEP ISO
RGD
PMID:17297389 , PMID:26699876 , PMID:20732338 , PMID:20012353
RGD:2315933 , RGD:13782283 , RGD:10053708 , RGD:2315928
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
G
Cav1
caveolin 1
treatment onset
ISO
protein:decreased expression:mammary gland
RGD
PMID:9685399 , PMID:15334058 , PMID:15355971
RGD:2289100 , RGD:8661780 , RGD:2289106
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
G
Ccna2
cyclin A2
ISO
protein:increased expression:mammary gland
RGD
PMID:10713672
RGD:2293347
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
G
Ccnb1
cyclin B1
ISO
RGD
PMID:11146550
RGD:2315939
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
G
Ccnd1
cyclin D1
ISO IEP
CTD Direct Evidence: marker/mechanism protein:decreased expression:mammary gland
CTD
PMID:12376462 PMID:14522882 PMID:16316942 , PMID:17440082 , PMID:12602925 , PMID:12649181
RGD:2296037 , RGD:2289337 , RGD:2289336
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Ccnd3
cyclin D3
IEP ISO
mRNA, protein:increased expression:mammary gland
RGD
PMID:16311245 , PMID:12853979
RGD:2316020 , RGD:2316015
NCBI chr 9:15,404,816...15,410,905
Ensembl chr 9:15,404,822...15,410,943
G
Ccne1
cyclin E1
IEP
protein:decreased expression:mammary gland
RGD
PMID:12649181 , PMID:12602925
RGD:2289336 , RGD:2289337
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
G
Ccnh
cyclin H
IEP ISO
mRNA:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953 , PMID:12606953
RGD:9590264
NCBI chr 2:13,593,100...13,613,910
Ensembl chr 2:13,593,100...13,613,910
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21621198
RGD:6893427
NCBI chr 8:133,026,539...133,040,999
Ensembl chr 8:133,029,625...133,040,997
G
Ccr5
C-C motif chemokine receptor 5
ISO
RGD
PMID:14597737 , PMID:22637726
RGD:8551810 , RGD:8551813
NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614
G
Cd274
CD274 molecule
treatment
IDA
RGD
PMID:29043842
RGD:40886270
NCBI chr 1:247,519,890...247,539,659
Ensembl chr 1:247,519,939...247,537,943
G
Cd40
CD40 molecule
ISO
RGD
PMID:21137078
RGD:8547744
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
G
Cd44
CD44 molecule (Indian blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
G
Cdc25a
cell division cycle 25A
ISO
RGD
PMID:17283130 , PMID:17638870 , PMID:16951165
RGD:2764000 , RGD:2754551 , RGD:2771824
NCBI chr 8:117,953,223...117,971,552
Ensembl chr 8:117,953,444...117,971,519
G
Cdc42
cell division cycle 42
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdh13
cadherin 13
severity
ISO
RGD
PMID:18316604 , PMID:18316604
RGD:2293540 , RGD:2293540
NCBI chr19:50,848,793...51,971,618
Ensembl chr19:50,848,736...51,972,103
G
Cdk2
cyclin dependent kinase 2
ISO
RGD
PMID:16924466
RGD:2293558
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
G
Cdk4
cyclin-dependent kinase 4
susceptibility
IEP ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:14522882 PMID:25221644 , PMID:14522882 , PMID:16413469
RGD:2293581 , RGD:2293577
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
G
Cdk6
cyclin-dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25221644
NCBI chr 4:27,781,728...27,969,653
Ensembl chr 4:27,785,647...27,966,398
G
Cdkl2
cyclin dependent kinase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25333262
NCBI chr14:17,530,170...17,565,950
Ensembl chr14:17,531,398...17,565,950
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
treatment
IEP IDA
protein:increased expression:mammary gland
RGD
PMID:15844214 , PMID:22651929
RGD:2293626 , RGD:10045559
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
disease_progression
ISO IEP
RGD
PMID:18060046 , PMID:20681787
RGD:2289674 , RGD:8552689
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
disease_progression
ISO
RGD
PMID:18060046
RGD:2289674
G
Cdkn2a_v2
cyclin-dependent kinase inhibitor 2A, variant 2
disease_progression
ISO
RGD
PMID:18060046
RGD:2289674
G
Cds1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
G
Clu
clusterin
disease_progression
ISO
RGD
PMID:23099883
RGD:8699504
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
G
Cnn3
calponin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:225,005,069...225,036,179
Ensembl chr 2:225,005,019...225,036,188
G
Col18a1
collagen type XVIII alpha 1 chain
severity
IDA
RGD
PMID:10766159
RGD:70690
NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858
G
Col5a1
collagen type V alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
G
Csf1
colony stimulating factor 1
ISO
RGD
PMID:15205327
RGD:2293710
NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560
G
Csn2
casein beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chr14:21,972,274...21,979,511
Ensembl chr14:21,972,274...21,979,510
G
Csn3
casein kappa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:21,803,738...21,810,291
Ensembl chr14:21,803,735...21,810,314
G
Csnk2a1
casein kinase 2 alpha 1
IEP ISO
RGD
PMID:11827167 , PMID:11827167
RGD:727632 , RGD:727632
NCBI chr 3:147,713,808...147,760,375
Ensembl chr 3:147,713,821...147,757,862
G
Ctnnb1
catenin beta 1
ISO
DNA:missense mutations: :p.S33Y, p.S45F protein:increased expression:mammary gland
RGD
PMID:18060046 , PMID:17510243
RGD:2289674 , RGD:2289816
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
G
Dbi
diazepam binding inhibitor, acyl-CoA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:36,147,667...36,156,076
Ensembl chr13:36,117,119...36,174,908
G
Ddr1
discoidin domain receptor tyrosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr20:3,553,430...3,574,959
Ensembl chr20:3,552,929...3,575,780
G
Des
desmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
G
Dio1
iodothyronine deiodinase 1
IDA
RGD
PMID:11765219
RGD:727335
NCBI chr 5:126,894,837...126,911,532
Ensembl chr 5:126,895,286...126,911,520
G
Dnmt3b
DNA methyltransferase 3 beta
treatment
IEP
RGD
PMID:24447120
RGD:9588304
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
G
Dusp1
dual specificity phosphatase 1
treatment
ISO
RGD
PMID:20837666
RGD:5129167
NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
G
Dusp6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:113,202,382...113,294,993
Ensembl chr14:113,202,419...113,295,014
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2523869 PMID:8603490 , PMID:17203220
RGD:2289979
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Eif5a
eukaryotic translation initiation factor 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:56,527,075...56,531,615
Ensembl chr10:56,527,085...56,531,483
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
G
Epcam
epithelial cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:11,282,194...11,308,870
Ensembl chr 6:11,281,964...11,298,216
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
G
Epo
erythropoietin
treatment
IMP
RGD
PMID:12118093
RGD:11041669
NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
G
Epor
erythropoietin receptor
treatment
IMP
RGD
PMID:12118093
RGD:11041669
NCBI chr 8:22,969,737...22,974,468
Ensembl chr 8:22,969,745...22,974,321
G
Erbb2
erb-b2 receptor tyrosine kinase 2
IDA ISO
Androgen-dependent CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490 PMID:25221644 , PMID:1913683 , PMID:12150826 , PMID:17203220
RGD:2289920 , RGD:6482679 , RGD:2289979
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644
G
Esr1
estrogen receptor 1
susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:epithelial cell, nucleus
CTD
PMID:15637090 , PMID:18055862 , PMID:11759285 , PMID:15637090
RGD:2290019 , RGD:8553057 , RGD:8552983
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Esr2
estrogen receptor 2
treatment
IDA ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:epithelial cell, nucleus
CTD
PMID:15637090 , PMID:24078029 , PMID:15637090
RGD:7364911 , RGD:8552983
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
G
Ezr
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
G
F11r
F11 receptor
ISO
RGD
PMID:22120722
RGD:7488922
NCBI chr13:89,826,272...89,850,151
Ensembl chr13:89,826,254...89,850,612
G
Fabp4
fatty acid binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
G
Fas
Fas cell surface death receptor
ISO
RGD
PMID:18094967
RGD:2290047
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Fbxo10
F-box protein 10
IEP
RGD
PMID:17404222
RGD:1601189
NCBI chr 5:60,589,881...60,636,551
Ensembl chr 5:60,591,023...60,658,564
G
Fgf10
fibroblast growth factor 10
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18421211
RGD:2292665
NCBI chr 2:51,673,480...51,747,533
Ensembl chr 2:51,672,722...51,750,369
G
Fgf7
fibroblast growth factor 7
ISO
RGD
PMID:9000125
RGD:2301094
NCBI chr 3:118,315,859...118,368,464
Ensembl chr 3:118,317,761...118,366,872
G
Fgf8
fibroblast growth factor 8
ISO
RGD
PMID:9840935
RGD:2301098
NCBI chr 1:265,492,949...265,498,965
Ensembl chr 1:265,493,124...265,498,831
G
Flt3
Fms related receptor tyrosine kinase 3
ISO
RGD
PMID:10498246
RGD:2302211
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
G
Fn1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
G
Frmpd1
FERM and PDZ domain containing 1
IEP
RGD
PMID:17404222
RGD:1601189
NCBI chr 5:60,735,413...60,837,773
Ensembl chr 5:60,809,762...60,837,764
G
Furin
furin (paired basic amino acid cleaving enzyme)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:142,185,092...142,198,167
Ensembl chr 1:142,185,094...142,197,182
G
G0s2
G0/G1switch 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
G
Gata3
GATA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
G
Gatm
glycine amidinotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:114,711,570...114,728,155
Ensembl chr 3:114,711,562...114,728,410
G
Gda
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
G
Gh1
growth hormone 1
treatment
IMP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD
PMID:12082019 PMID:15528971 PMID:17584969 , PMID:17584969 , PMID:6139974
RGD:2315650 , RGD:11352806
NCBI chr10:94,486,204...94,488,181
Ensembl chr10:94,486,205...94,488,180
G
Gnai2
G protein subunit alpha i2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:116,370,730...116,391,337
Ensembl chr 8:116,370,744...116,391,307
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
RGD
PMID:28810530
RGD:13792729
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
G
Gsn
gelsolin
IEP
mRNA:decreased expression
RGD
PMID:8895730
RGD:1599869
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
G
Gss
glutathione synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557
G
H19
H19, imprinted maternally expressed transcript (non-protein coding)
IEP
RGD
PMID:15170812
RGD:1642758
NCBI chr 1:215,744,404...215,747,080
G
H2ax
H2A.X variant histone
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
G
H3f3b
H3.3 histone B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:104,573,666...104,575,890
Ensembl chr10:104,573,664...104,575,890
G
Hba-a2
hemoglobin alpha, adult chain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:15,589,364...15,590,207
Ensembl chr10:15,589,364...15,590,220
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IDA
RGD
PMID:17280655
RGD:2293194
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
G
Hmox1
heme oxygenase 1
treatment
IDA ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16319139 , PMID:23215791
RGD:10755708
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:144,865,302...144,871,592
Ensembl chr 7:144,865,608...144,871,585
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15538050
NCBI chr10:34,955,713...34,961,662
Ensembl chr10:34,955,716...34,961,608 Ensembl chr10:34,955,716...34,961,608
G
Hp
haptoglobin
treatment
IDA
RGD
PMID:23880232
RGD:11041861
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
G
Hras
HRas proto-oncogene, GTPase
IAGP ISO
DNA:mutation: :p.G12E (rat) CTD Direct Evidence: marker/mechanism
CTD
PMID:8185828 PMID:11376698 , PMID:19652463
RGD:2314834
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
G
Id1
inhibitor of DNA binding 1, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 3:148,214,623...148,216,715
Ensembl chr 3:148,215,540...148,216,718
G
Id3
inhibitor of DNA binding 3, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
G
Id4
inhibitor of DNA binding 4, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14633621
NCBI chr17:16,692,557...16,695,126
Ensembl chr17:16,692,557...16,695,126
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15217511 PMID:15528971 PMID:17584969 , PMID:23342276
RGD:8549490
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14999141
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il18bp
interleukin 18 binding protein
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr 1:167,091,521...167,095,727
Ensembl chr 1:167,091,522...167,093,560
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:44,279,199...44,319,427
Ensembl chr 2:44,289,393...44,314,944
G
Ilk
integrin-linked kinase
ISO
late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands
RGD
PMID:11704830
RGD:2301733
NCBI chr 1:170,578,941...170,585,192
Ensembl chr 1:170,578,889...170,585,189
G
Insig1
insulin induced gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
G
Itgb3
integrin subunit beta 3
IEP
protein:increased expression:mammary gland:
RGD
PMID:22022542
RGD:8693386
NCBI chr10:92,667,869...92,783,413
Ensembl chr10:92,667,869...92,783,410
G
Kdr
kinase insert domain receptor
IDA ISO
inhibition prevents DMBA-induced atypical ductal hyperplasia and carcinoma in situ
RGD
PMID:15170218 , PMID:19888452
RGD:2291936 , RGD:5684399
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Kit
KIT proto-oncogene receptor tyrosine kinase
IAGP
DNA:mutation (rat)
RGD
PMID:18445266
RGD:2302172
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
G
Krt5
keratin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:143,320,142...143,324,536
Ensembl chr 7:143,316,920...143,453,546
G
Krt7
keratin 7
IEP
RGD
PMID:8570173
RGD:2317439
NCBI chr 7:143,059,731...143,075,907
Ensembl chr 7:143,059,764...143,075,907
G
Krt71
keratin 71
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:143,345,201...143,371,346
Ensembl chr 7:143,345,201...143,353,925
G
Lep
leptin
treatment
IEP
RGD
PMID:22246620
RGD:8694468
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
G
Lgals7
galectin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:87,044,823...87,047,223
Ensembl chr 1:87,045,335...87,047,223
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
IMP
mRNA:splice variant (rat)
RGD
PMID:15044717
RGD:2302177
NCBI chr 6:12,493,182...12,554,482
Ensembl chr 6:12,493,943...12,554,439
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:49,429,613...49,627,835
Ensembl chr 7:49,385,705...49,656,856
G
Lnpep
leucyl and cystinyl aminopeptidase
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD
PMID:16619500 , PMID:16619500
RGD:1582109
NCBI chr 1:59,289,392...59,384,540
Ensembl chr 1:59,297,294...59,347,472 Ensembl chr 1:59,297,294...59,347,472
G
Lpl
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
G
Lsr
lipolysis stimulated lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:89,383,515...89,399,041
Ensembl chr 1:89,383,519...89,399,041
G
Map2k3
mitogen activated protein kinase kinase 3
ISO
RGD
PMID:24233520
RGD:7495808
NCBI chr10:45,089,455...45,110,802
Ensembl chr10:47,182,433...47,203,753 Ensembl chr10:47,182,433...47,203,753
G
Map2k7
mitogen activated protein kinase kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21317887
NCBI chr12:2,546,278...2,555,310
Ensembl chr12:2,548,218...2,555,164
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
RGD
PMID:29435821
RGD:13800872
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:29435821
RGD:13800872
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mdh2
malate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:23,941,451...23,954,406
Ensembl chr12:23,941,448...23,954,431
G
Mgp
matrix Gla protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 4:170,856,783...170,860,105
Ensembl chr 4:170,856,751...170,860,225
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
G
Mir155
microRNA 155
ISO
RGD
PMID:20354188 , PMID:29643534
RGD:21079418 , RGD:21403681
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
G
Mmp1
matrix metallopeptidase 1
treatment
ISO
RGD
PMID:19622769
RGD:8549722
NCBI chr 8:5,703,206...5,723,593
Ensembl chr 8:5,703,206...5,723,591
G
Mmp13
matrix metallopeptidase 13
severity
ISO
RGD
PMID:18698413
RGD:2306081
NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
G
Mmp15
matrix metallopeptidase 15
ISO
mRNA:increased expression:mammary gland
RGD
PMID:15895410
RGD:2314949
NCBI chr19:10,079,881...10,101,380
Ensembl chr19:10,079,765...10,101,451
G
Mmp2
matrix metallopeptidase 2
treatment
IEP ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:28574600 , PMID:19725228 , PMID:23359979
RGD:2325823 , RGD:8657038
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp3
matrix metallopeptidase 3
IMP
RGD
PMID:10428026
RGD:8662909
NCBI chr 8:5,676,608...5,698,579
Ensembl chr 8:5,676,665...5,698,579
G
Mmp7
matrix metallopeptidase 7
onset
ISO
RGD
PMID:9850086
RGD:9685350
NCBI chr 8:5,893,253...5,900,965
Ensembl chr 8:5,893,249...5,901,049
G
Mmp9
matrix metallopeptidase 9
treatment
IEP ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680 , PMID:19725228 , PMID:23359979
RGD:2325823 , RGD:8657038
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Mpzl1
myelin protein zero-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:83,805,244...83,842,074
Ensembl chr13:83,805,244...83,842,051
G
Mrc2
mannose receptor, C type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:93,520,272...93,581,599
Ensembl chr10:93,520,132...93,581,296
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mtor
mechanistic target of rapamycin kinase
IMP
RGD
PMID:22349822
RGD:10040957
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
G
Muc1
mucin 1, cell surface associated
treatment
ISO
RGD
PMID:23015160
RGD:7349374
NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
G
Myc
MYC proto-oncogene, bHLH transcription factor
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
G
Ncoa1
nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21080969
NCBI chr 6:28,677,563...28,931,844
Ensembl chr 6:28,677,540...28,931,843
G
Nfe2l2
nuclear factor, erythroid 2-like 2
treatment
IEP
RGD
PMID:22072621
RGD:10412719
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Notch4
notch receptor 4
ISO
RGD
PMID:15531924
RGD:2299154
NCBI chr20:4,329,794...4,353,868
Ensembl chr20:4,329,811...4,353,785
G
Nsmf
NMDA receptor synaptonuclear signaling and neuronal migration factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:2,262,173...2,270,996
Ensembl chr 3:2,262,253...2,270,995
G
Nudt1
nudix hydrolase 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:12036445
RGD:724605
NCBI chr12:16,391,578...16,398,771
Ensembl chr12:16,391,578...16,395,029
G
Oxt
oxytocin/neurophysin I prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8647655 PMID:15089975
NCBI chr 3:123,106,694...123,107,534
Ensembl chr 3:123,106,694...123,107,534
G
Padi4
peptidyl arginine deiminase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:159,260,675...159,293,906
Ensembl chr 5:159,260,675...159,293,673
G
Pak4
p21 (RAC1) activated kinase 4
ISO
RGD
PMID:20697354
RGD:7775027
NCBI chr 1:85,162,462...85,201,746
Ensembl chr 1:85,162,452...85,201,757
G
Parp1
poly (ADP-ribose) polymerase 1
treatment
IDA
RGD
PMID:23404339
RGD:10053670
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Pcna
proliferating cell nuclear antigen
IEP
mRNA,protein:increased expression:mammary gland:
RGD
PMID:2567593
RGD:10448972
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
G
Pcp4
Purkinje cell protein 4
IEP
mRNA,protein:increased expression:cytoplasm:
RGD
PMID:19480007
RGD:9850273
NCBI chr11:36,851,035...36,912,272
Ensembl chr11:36,851,038...36,912,229
G
Pdgfa
platelet derived growth factor subunit A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr12:17,734,141...17,756,186
Ensembl chr12:17,734,133...17,755,285
G
Pebp1
phosphatidylethanolamine binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:45,026,948...45,031,148
Ensembl chr12:45,026,886...45,031,145
G
Pgam1
phosphoglycerate mutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:261,158,204...261,165,814
Ensembl chr 1:261,158,261...261,165,808
G
Pgr
progesterone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15637090
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
G
Phb
prohibitin
IEP ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 , PMID:12376462
RGD:2292404
NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Pin1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
IEP
RGD
PMID:22064478
RGD:8693420
NCBI chr 8:21,669,236...21,680,615
Ensembl chr 8:21,669,236...21,680,615
G
Pkm
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:64,480,963...64,502,957
Ensembl chr 8:64,481,172...64,502,722
G
Plau
plasminogen activator, urokinase
disease_progression
IMP
RGD
PMID:18052026
RGD:6484140
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
G
Plk2
polo-like kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11137312
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
G
Prdx2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:26,084,816...26,090,095
Ensembl chr19:26,084,903...26,090,094
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
G
Prlr
prolactin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:60,131,410...60,325,686
Ensembl chr 2:60,131,776...60,325,692
G
Psma4
proteasome 20S subunit alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:59,532,456...59,539,916
Ensembl chr 8:59,532,389...59,539,920
G
Psme1
proteasome activator subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:34,256,071...34,258,947
Ensembl chr15:34,256,071...34,258,947
G
Ptbp1
polypyrimidine tract binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:12,663,965...12,673,723
Ensembl chr 7:12,663,965...12,673,718
G
Pten
phosphatase and tensin homolog
onset
ISO
RGD
PMID:18381417
RGD:2292496
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
G
Ptger1
prostaglandin E receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11751431
NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP ISO IMP
mRNA:increased expression:breast
RGD
PMID:21623034 , PMID:18676768 , PMID:18279516
RGD:5135030 , RGD:2300118 , RGD:2300130
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Ptk2
protein tyrosine kinase 2
disease_progression
ISO IMP
CTD Direct Evidence: therapeutic
CTD
PMID:24809783 , PMID:18056629 , PMID:15930288
RGD:2292554 , RGD:2292560
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
G
Ptn
pleiotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:64,239,156...64,330,996
Ensembl chr 4:64,239,158...64,330,996
G
Ran
RAN, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr12:31,319,556...31,324,105
Ensembl chr12:31,320,624...31,323,810
G
Rasa1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:13,617,021...13,696,531
Ensembl chr 2:13,616,822...13,696,426
G
Rasgrf2
RAS protein-specific guanine nucleotide-releasing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:21,460,041...21,698,937
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14522882
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
G
Rbp1
retinol binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 8:106,449,321...106,470,842
Ensembl chr 8:106,449,321...106,470,842
G
Rbp4
retinol binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:256,806,476...256,813,678
Ensembl chr 1:256,806,472...256,813,711
G
Rcn1
reticulocalbin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:95,404,863...95,419,110
Ensembl chr 3:95,406,284...95,418,679
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
protein:decreased expression:peritoneal macrophage
RGD
PMID:16288051
RGD:2298764
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Relb
RELB proto-oncogene, NF-kB subunit
ISO
RGD
PMID:16260626
RGD:7777148
NCBI chr 1:80,517,081...80,545,019
Ensembl chr 1:80,517,411...80,544,825
G
Rnpep
arginyl aminopeptidase
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD
PMID:16619500 , PMID:16619500
RGD:1582109
NCBI chr13:52,092,863...52,124,006
Ensembl chr13:52,092,859...52,111,363
G
Rpl3
ribosomal protein L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:121,297,365...121,302,739
Ensembl chr 7:121,297,355...121,311,565
G
Rpl6
ribosomal protein L6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:40,877,578...40,882,032
Ensembl chr12:40,877,613...40,881,124
G
Rps14
ribosomal protein S14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr18:56,042,532...56,047,316
Ensembl chr18:56,044,369...56,047,316
G
Rxra
retinoid X receptor alpha
IMP
RGD
PMID:16344269
RGD:1643109
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
G
S100a6
S100 calcium binding protein A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:190,007,013...190,008,512
Ensembl chr 2:190,007,216...190,008,511
G
S1pr1
sphingosine-1-phosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:218,654,406...218,658,761
Ensembl chr 2:218,654,554...218,658,761
G
Scarb1
scavenger receptor class B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:36,694,952...36,761,445
Ensembl chr12:36,694,960...36,761,455
G
Scd
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:264,159,966...264,173,061
Ensembl chr 1:264,160,129...264,172,729
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858
G
Sgk1
serum/glucocorticoid regulated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:24,185,451...24,302,309
Ensembl chr 1:24,185,435...24,302,298
G
Slc12a2
solute carrier family 12 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr18:52,917,124...52,985,281
Ensembl chr18:52,917,124...52,985,261
G
Slc25a10
solute carrier family 25 member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:109,665,682...109,674,782
Ensembl chr10:109,665,682...109,673,143
G
Sncg
synuclein, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:10,722,110...10,726,648
Ensembl chr16:10,722,106...10,726,707
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr20:14,080,562...14,095,644
Ensembl chr20:14,080,565...14,095,181
G
Socs1
suppressor of cytokine signaling 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452 , PMID:20354188
RGD:2298899 , RGD:21079418
NCBI chr10:4,956,795...4,958,472
Ensembl chr10:4,957,326...4,958,461
G
Socs3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452
RGD:2298899
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23964924
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
G
Sox9
SRY-box transcription factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379
G
Spint2
serine peptidase inhibitor, Kunitz type, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:87,199,373...87,221,826
Ensembl chr 1:87,199,313...87,221,892
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15318939
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
G
Srsf2
serine and arginine rich splicing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:105,792,779...105,795,986
Ensembl chr10:105,792,779...105,795,958
G
Stat1
signal transducer and activator of transcription 1
ISO
RGD
PMID:11325527
RGD:2291895
NCBI chr 9:54,287,540...54,327,958
Ensembl chr 9:54,287,541...54,484,533
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942 , PMID:17483332
RGD:2291914
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Stat5a
signal transducer and activator of transcription 5A
susceptibility
IEP ISO
protein:increased tyrosine phosphorylation:mammary gland CTD Direct Evidence: marker/mechanism protein:altered localization:nucleus
CTD
PMID:12376462 PMID:15609129 PMID:16316942 , PMID:17173897 , PMID:15609129 , PMID:12082622
RGD:2291927 , RGD:2291932 , RGD:2298539
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
G
Stat6
signal transducer and activator of transcription 6
ISO
RGD
PMID:11086031
RGD:2298563
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
G
Stc2
stanniocalcin 2
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr10:16,542,909...16,552,675
Ensembl chr10:16,542,882...16,553,295
G
Stmn1
stathmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:152,680,412...152,686,807
Ensembl chr 5:152,680,407...152,686,806
G
Tdg
thymine-DNA glycosylase
ISO
mRNA:increased expression:mammary gland tumor (mouse)
RGD
PMID:9794235
RGD:2317355
NCBI chr 7:27,194,000...27,213,676
Ensembl chr 7:27,193,998...27,214,236
G
Terc
telomerase RNA component
ISO
RNA:increased expression:mammary gland
RGD
PMID:9857231
RGD:2291975
NCBI chr 2:116,432,723...116,433,110
Ensembl chr 2:116,432,691...116,433,110
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
G
Tff1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr20:9,892,124...9,895,984
Ensembl chr20:9,892,124...9,895,984
G
Tgfa
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490
NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
G
Tgfb1
transforming growth factor, beta 1
ISO
RGD
PMID:8466857
RGD:7394797
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
G
Tgfbr1
transforming growth factor, beta receptor 1
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr 5:63,056,071...63,119,635
Ensembl chr 5:63,050,758...63,119,635
G
Tgfbr2
transforming growth factor, beta receptor 2
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494
G
Thbs1
thrombospondin 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:15459484
RGD:1626167
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
G
Thrsp
thyroid hormone responsive
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:162,381,251...162,385,575
Ensembl chr 1:162,381,253...162,385,575
G
Tkt
transketolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:6,609,670...6,634,608
Ensembl chr16:6,609,668...6,634,595
G
Tle4
TLE family member 4, transcriptional corepressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:231,394,606...231,531,396
Ensembl chr 1:231,393,379...231,530,786
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:19755514
RGD:7401185
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 Ensembl chr20:5,189,390...5,192,000
G
Tnfrsf10b
TNF receptor superfamily member 10b
ISO
RGD
PMID:17671220
RGD:2290495
NCBI chr15:51,433,853...51,464,215
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21252285
NCBI chr 2:113,008,008...113,026,899
Ensembl chr 2:113,007,549...113,026,899
G
Tp53
tumor protein p53
disease_progression
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24809783 , PMID:17470299 , PMID:18092324
RGD:2290577 , RGD:2290539
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tpm3
tropomyosin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:189,423,534...189,451,340
Ensembl chr 2:189,423,559...189,451,029
G
Trps1
transcriptional repressor GATA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:90,085,895...90,320,430
Ensembl chr 7:90,090,828...90,318,221
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:58,554,358...58,658,156
Ensembl chr15:58,554,374...58,658,153
G
Tubb2b
tubulin, beta 2B class IIb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr17:31,441,640...31,444,687
Ensembl chr17:31,441,630...31,482,759
G
Txnip
thioredoxin interacting protein
severity
IEP
mRNA:decreased expression:mammary gland
RGD
PMID:15170812
RGD:1642758
NCBI chr 2:198,683,168...198,686,971
Ensembl chr 2:198,683,159...198,686,974
G
Tyms
thymidylate synthetase
IMP
RGD
PMID:9635926
RGD:2315839
NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
G
Ube2i
ubiquitin-conjugating enzyme E2I
ISO
MCF-7 human breast cancer cell tumors grown in nude mice CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942 , PMID:15735760
RGD:2301345
NCBI chr10:14,618,615...14,639,274
Ensembl chr10:14,620,531...14,630,151
G
Ucp2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
G
Vamp8
vesicle-associated membrane protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:100,250,301...100,252,756
Ensembl chr 4:100,250,301...100,252,755
G
Vdr
vitamin D receptor
ISO
RGD
PMID:15333467
RGD:8158073
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Wnt1
Wnt family member 1
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 7:140,464,999...140,469,046
Ensembl chr 7:140,464,999...140,469,046
G
Wnt2
Wnt family member 2
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:45,286,845...45,332,899
Ensembl chr 4:45,292,437...45,332,420
G
Wnt3
Wnt family member 3
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:9419423
RGD:2298848
NCBI chr10:91,830,709...91,874,907
Ensembl chr10:91,830,654...91,874,793
G
Wnt3a
Wnt family member 3A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:9419423 , PMID:8065359
RGD:2298848 , RGD:2298863
NCBI chr10:45,598,898...45,643,151
Ensembl chr10:45,598,912...45,638,035
G
Wnt5b
Wnt family member 5B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:151,500,962...151,516,894
Ensembl chr 4:151,500,957...151,516,894
G
Wnt6
Wnt family member 6
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 9:82,033,543...82,047,172
Ensembl chr 9:82,033,543...82,047,166
G
Wnt7a
Wnt family member 7A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:122,994,425...123,040,609
Ensembl chr 4:122,994,425...123,040,609
G
Wnt7b
Wnt family member 7B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 , PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 7:126,423,418...126,465,724
Ensembl chr 7:126,420,656...126,465,723
G
Xdh
xanthine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
G
Xiap
X-linked inhibitor of apoptosis
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12766084
NCBI chr X:128,409,425...128,455,786
Ensembl chr X:128,409,472...128,453,000
G
Xrcc3
X-ray repair cross complementing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 6:136,366,917...136,380,751
Ensembl chr 6:136,371,555...136,379,348
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:75,573,553...75,598,295
Ensembl chr 7:75,574,967...75,597,276
G
Rhob
ras homolog family member B
IDA
RGD
PMID:1710770
RGD:704375
NCBI chr 6:33,689,127...33,691,301
Ensembl chr 6:33,689,127...33,691,301
G
Dpyd
dihydropyrimidine dehydrogenase
treatment
IMP
RGD
PMID:8138551
RGD:11251753
NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
disease
16158
disease of cellular proliferation
5940
Experimental Neoplasms
605
Carcinoma 256, Walker
0
Carcinoma, Brown-Pearce
0
Carcinoma, Krebs 2
0
Carcinoma, Lewis Lung
8
Ehrlich tumor carcinoma
2
Experimental Leukemia +
7
Experimental Liver Neoplasms
183
Experimental Melanoma
23
Experimental Sarcoma +
9
Mammary Neoplasms, Experimental
384
Path 2
disease
16158
Animal Diseases
1653
Animal Disease Models
1606
Experimental Neoplasms
605
Carcinoma 256, Walker
0
Carcinoma, Brown-Pearce
0
Carcinoma, Krebs 2
0
Carcinoma, Lewis Lung
8
Ehrlich tumor carcinoma
2
Experimental Leukemia +
7
Experimental Liver Neoplasms
183
Experimental Melanoma
23
Experimental Sarcoma +
9
Mammary Neoplasms, Experimental
384